Parkinsonism among Gaucher disease carriers

被引:272
作者
Goker-Alpan, O
Schiffmann, R
LaMarca, ME
Nussbaum, RL
McInerney-Leo, A
Sidransky, E
机构
[1] NIMH, Sect Mol Neurogenet, NIH, Bethesda, MD 20892 USA
[2] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA
[3] Natl Inst Neurol Disorders & Stroke, Dev & Metab Neurol Branch, NIH, Bethesda, MD USA
[4] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1136/jmg.2004.024455
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
An association between Gaucher disease and Parkinson disease has been demonstrated by the concurrence of Gaucher disease and parkinsonism in rare patients and the identification of glucocerebrosidase mutations in probands with sporadic Parkinson disease. Using a different and complementary approach, we describe 10 unrelated families of subjects with Gaucher disease where obligate or confirmed carriers of glucocerebrosidase mutations developed parkinsonism. These observations indicate that mutant glucocerebrosidase, even in heterozygotes, may be a risk factor for the development of parkinsonism. Understanding the relationship between altered glucocerebrosidase and the development of parkinsonian manifestations will provide insights into the genetics, pathogenesis, and treatment of Parkinson disease.
引用
收藏
页码:937 / 940
页数:4
相关论文
共 15 条
[1]   Gaucher's disease with Parkinson's disease - Clinical and pathological aspects [J].
Bembi, B ;
Marsala, SZ ;
Sidransky, E ;
Ciana, G ;
Carrozzi, M ;
Zorzon, M ;
Martini, C ;
Gioulis, M ;
Pittis, MG ;
Capus, L .
NEUROLOGY, 2003, 61 (01) :99-101
[2]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[3]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[4]   Glycerol as a correlate of impaired glucose tolerance:: Dissection of a complex system by use of a simple genetic trait [J].
Gaudet, D ;
Arsenault, S ;
Pérusse, L ;
Vohl, MC ;
St-Pierre, J ;
Bergeron, J ;
Després, JP ;
Dewar, K ;
Daly, MJ ;
Hudson, T ;
Rioux, JD .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (05) :1558-1568
[5]   Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia [J].
Kanavakis, E ;
Tzetis, M ;
Antoniadi, T ;
Pistofidis, G ;
Milligos, S ;
Kattamis, C .
MOLECULAR HUMAN REPRODUCTION, 1998, 4 (04) :333-337
[6]   Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease - Evidence that all three MTHFR C677T genotypes confer different levels of risk [J].
Kluijtmans, LAJ ;
Whitehead, AS .
EUROPEAN HEART JOURNAL, 2001, 22 (04) :294-299
[7]   Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease [J].
Koprivica, V ;
Stone, DL ;
Park, JK ;
Callahan, M ;
Frisch, A ;
Cohen, IJ ;
Tayebi, N ;
Sidransky, E .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) :1777-1786
[8]   Glucocerebrosidase mutations in subjects with parkinsonism [J].
Lwin, A ;
Orvisky, E ;
Goker-Alpan, O ;
LaMarca, ME ;
Sidransky, E .
MOLECULAR GENETICS AND METABOLISM, 2004, 81 (01) :70-73
[9]   Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis [J].
Mahadeva, R ;
Chang, WSW ;
Dafforn, TR ;
Oakley, DJ ;
Foreman, RC ;
Calvin, J ;
Wight, DGD ;
Lomas, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (07) :999-1006
[10]  
Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691